Differential importance of MSP4 and MSP5 for infection of red blood cells between human infecting malaria parasites
Jill ChmielewskiiD, Isabelle G. HenshalliD, Ornella RomeoiD, Danny William WilsoniD
Abstract
Plasmodium species malaria parasites require invasion and replication within red blood cells to cause disease. Merozoite surface proteins (MSPs) are proposed to play a role in attachment of merozoites to RBCs and have long been considered as potential vaccine targets, but their functions during invasion are largely unknown. We applied targeted gene editing to investigate MSP4 and 5 function in P. falciparum, which causes most malaria mortality, and P. knowlesi, an in vitro culturable zoonotic species closely related to the widespread P. vivax. CRISPR-Cas9 gene-editing revealed that P. knowlesi MSP4 was not required for parasite growth in vitro. While P. knowlesi MSP5 could be functionally replaced by P. vivax MSP5, it was refractory to gene deletion. We confirmed the opposite for two different P. falciparum laboratory isolates where MSP4 is essential but MSP5 is dispensable. Attempts to select for reliance on the non-essential MSP (e.g. P. knowlesi MSP4 or P. falciparum MSP5) through long-term growth of inducible knock-out parasites, or via chimeric complementation of the essential MSP4 or 5 with the essential MSP from the other species, were unsuccessful. Live cell filming revealed a severe cell-entry defect with conditional knock-down of MSP5 protein expression in P. knowlesi. This study demonstrates differential importance of MSP4 and MSP5 during merozoite RBC invasion across human infecting malaria species, emphasises that vaccine candidates must be considered individually for the two most prominent human malarias and promotes MSP5 as a potential vaccine candidate for P. knowlesi and P. vivax. SignificanceFor a malaria parasite to cause disease, the merozoite form of the lifecycle has to infect and replicate within human red blood cells. Proteins on the surface of the merozoite are considered as promising vaccine candidates, but the functions of these proteins are poorly understood. Here we demonstrate that two structurally similar merozoite surface proteins (MSP), MSP4 and MSP5, have differential importance between one human infecting malaria species compared to a second. The finding that MSP4 is essential for growth in one species, and MSP5 in the other, has implications for understanding invasion biology of malaria parasites and highlights that even structurally similar vaccine targets may need to be chosen specifically for each human infecting malaria species.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- An abundant merozoite surface protein of Plasmodium falciparum modulates susceptibility to inhibitory antibodies
Isabelle G. Henshall, Jill Chmielewski, … Danny William Wilson·eLifePeer-reviewed·Jul 27, 2026
- Functional analysis of novel microneme proteins from Plasmodium vivax blood stages identifies vaccine candidates
Arunaditya Deshmukh, Francisco José Martínez Martínez, … Chetan E. Chitnis·bioRxiv·Aug 7, 2026
- Sequential roles for red blood cell binding proteins enable phased commitment to invasion for malaria parasites
M. N. Hart, F. Mohring, … R. W. Moon·bioRxiv·Aug 9, 2022
- Optical tweezers reveal that PfEBA and PfRH ligands, not PfMSP1, play a central role in Plasmodium-falciparum merozoite-erythrocyte attachment
Emma Kals, Morten Kals, … Julian C. Rayner·bioRxiv·Feb 13, 2024
- PTRAMP, CSS and Ripr form a conserved complex required for merozoite invasion of Plasmodium species into erythrocytes
Benjamin A. Seager, Pailene S. Lim, … Stephen W. Scally·Nature CommunicationsPeer-reviewed·Jan 26, 2026
- Targeting a malaria merozoite surface protein with mRNA vaccine generates multifunctional antibodies
Adam Thomas, Tom Runz, … James G. Beeson·Frontiers in ImmunologyPeer-reviewed·Sep 16, 2026